Call Now

Mouse IL17RA / IL17R / CD217 Protein (Fc Tag)

AW538159,Cdw217,Il17r,VDw217

Catalog Number P50328-M02H
Organism Species Mouse
Host Human Cells
Synonyms AW538159,Cdw217,Il17r,VDw217
Molecular Weight The recombinant mouse IL17RA/Fc is a disulfide-linked homodimer. The reduced monomer comprises 532 amino acids and has a predicted molecular mass of 60.3 kDa. The apparent molecular mass of the protein is approximately 67-77 and 118 kDa in SDS-PAGE under reducing conditions due to glycosylation.
predicted N Ser 32
SDS-PAGE
Purity (14.8+80.1) % as determined by SDS-PAGE
Protein Construction A DNA sequence encoding the mouse IL17RA (Q60943)(Met1-Trp322) was expressed with the Fc region of human IgG1 at the C-terminus.
Bio-activity Measured by its binding ability in a functional ELISA.
Immobilized mouse IL17A (P51065-MNAE) at 10 μg/ml (100 μl/well) can bind mouse IL17RA-Fc (cat: 50328-M02H), The EC50 of mouse IL17RA-Fc (cat: 50328-M02H) is 0.28-0.64 μg/ml.
Research Area Immunology |Adaptive Immunity |T Cell |T Cell CD Antigen |CD Antigen (Helper T Cells)
Formulation Lyophilized from sterile PBS, pH 7.4.
1. Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.
Background Interleukin-17 receptor (IL-17R), also known as Interleukin-17 receptor A (IL-17RA) and CD217 antigen (CD217), is a cytokine receptor which binds interleukin 17. IL-17R/IL-17RA (CD217) is a proinflammatory cytokine secreted by activated T-lymphocytes. It is a potent inducer of the maturation of CD34-positive hematopoietic precursors into neutrophils. IL-17R/IL-17RA (CD217) is a ubiquitous type I membrane glycoprotein that binds with low affinity to interleukin 17A. Interleukin 17A and its receptor IL-17RA play a pathogenic role in many inflammatory and autoimmune diseases such as rheumatoid arthritis. Like other cytokine receptors, this receptor likely has a multimeric structure. Defects in IL-17R/IL-17RA (CD217) are the cause of familial candidiasis type 5 (CANDF5). CANDF5 is a rare disorder with altered immune responses and impaired clearance of fungal infections, selective against Candida. It is characterized by persistent and/or recurrent infections of the skin, nails and mucous membranes caused by organisms of the genus Candida, mainly Candida albicans.
Reference
  • Gaffen SL. (2009) Structure and signalling in the IL-17 receptor family. Nat Rev Immunol. 9 (8): 556-67.
  • Johansen C, et al.. (2009) Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. Br J Dermatol. 160 (2): 319-24.
  • Yao Z, et al.. (1997) Molecular characterization of the human interleukin (IL)-17 receptor. Cytokine 9 (11): 794-800.